Fagron Concepts

An innovative vehicle range for the compounding of oral liquid dosage forms.
An innovative line of hair loss treatment solutions.
An innovative solution for dermatological care.

Brand New Compatibility Study for SyrSpend® SF!

Wed, 14/06/2017
Brand New Compatibility Study for SyrSpend® SF!

A new study has been conducted to evaluate the stability of 10 most commonly used API's compounded in SyrSpend® SF:

Alprazolam 1.0mg/mL
Atropine Sulphate 0.1mg/mL
Glutamine 250.0mg/mL
Levofloxacin 50.0 mg, mL
Metoprolol Tartrate 10.0 mg, mL
Nitrofurantoin 2.0mg, mL
Ondansetron Hydrochloride 0.8 mg/mL
Oxandrolone 3.0 mg/mL
Pregabalin 20.0mg/mL
Riboflavin 10.0mg/mL

 

All suspensions were stored at both controlled refrigeration and controlled room temperatures. The stability for each suspension was verified by high-performance liquid chromotography to measure to quantity of the API remaining over a certain period of time.

The study found that the suspensions had reached beyond-use-date past 90 days, suggesting that SyrSpend® SF PH4 is stable when used with the different pharmacological classes of active pharmaceutical ingredients.

View the entire article below.